Stockreport

MaxCyte Inc (MXCT) Q4 2025 Earnings Call Highlights: Navigating Revenue Declines Amid Strategic ... [Yahoo! Finance]

MaxCyte, Inc.  (MXCT) 
PDF Fourth Quarter Revenue (2025): $7.3 million, a 16% decline from Q4 2024. Core Revenue (2025): $29.6 million, a 9% decrease from 2024. Core Revenue (Q4 2025): $6.8 m [Read more]